Barclays’s Genprex GNPX Stock Holding History

Barclays’s Portfolio GNPX Stock Details GNPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$819	Buy	+72	New	+$1.38K	﹤0.01%	4950
2022 Q3	–	Hold	0	–	-$8K	–	4917
2022 Q2	–	Hold	0	–	–	–	4688
2022 Q1	–	Hold	0	–	–	–	4550
2021 Q4	–	Hold	0	–	–	–	4012
2021 Q3	–	Hold	0	–	–	–	4313
2021 Q2	–	Sell	-1	Closed	-$164K	–	4228
2021 Q1	$109K	Buy	+1	New	+$220K	﹤0.01%	3966
2020 Q4	–	Hold	0	–	–	–	4512
2020 Q3	–	Sell	-2	Closed	-$315K	–	4571
2020 Q2	$247K	Buy	+2	New	+$245K	﹤0.01%	3901
2020 Q1	–	Hold	0	–	–	–	6251
2019 Q4	–	Hold	0	–	–	–	6514

Other funds holding GNPX

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Engineers Gate Manager New York $7.71B AUM 24.88% 1-Year Est. Return

Mayflower Financial Advisors Boston, Massachusetts $1.16B AUM 24.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return

Cheviot Value Management Beverly Hills, California $984M AUM 24.46% 1-Year Est. Return

Barclays's GNPX Position: Q2 2026 in Review

Barclays opened a new position in Genprex (GNPX) in Q2 2026: 72 shares worth $819. The stake represents ﹤0.01% of the portfolio and ranks #4950 among its holdings. This is a return to the name: Barclays previously reported a position in GNPX as recently as Q1 2021.

Barclays first reported a position in GNPX in Q2 2020 and has held it in 3 quarters since. The position peaked at $247K in Q2 2020. 17 funds tracked by Wall St. Rank hold GNPX as of Q2 2026.

Barclays held 72 shares of Genprex worth $819 as of Q2 2026.
Genprex was a new Barclays position in Q2 2026.
Genprex made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4950 holding.
Barclays first reported a position in Genprex in Q2 2020 and has held it in 3 quarters since.
Barclays's Genprex position peaked at $247K in Q2 2020.
17 funds tracked by Wall St. Rank held Genprex as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.